Literature DB >> 24838047

Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity.

Frank M Schmidt1, Nicole Lichtblau2, Juliane Minkwitz3, Tobias Chittka3, Julia Thormann3, Kenneth C Kirkby4, Christian Sander5, Roland Mergl5, Mathias Faßhauer6, Michael Stumvoll6, Lesca M Holdt7, Daniel Teupser7, Ulrich Hegerl5, Hubertus Himmerich3.   

Abstract

In major depressive disorder, changes in cytokine levels have been reported to play a role in pathogenesis. Therefore, we sought to investigate a broad range of cytokines in depression. We compared serum levels of interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12, IL-13, granulocyte macrophage colony-stimulating factor (GM-CSF), interferon (INF-γ) and tumor necrosis factor (TNF)-α in 64 subjects with current depression and 206 non-depressed subjects. Depressed patients had higher levels of IL-2, IL-5, IL-12, IL-13, GM-CSF, INF-γ and TNF-α, compared to non-depressed subjects. Splitting groups into non-obese (BMI < 30) and obese (BMI ≥ 30), the non-obese depressed patients (n = 40) showed elevated IL-5, IL-12, IL-13, GM-CSF, INF-γ and TNF-α levels compared to non-obese and non-depressed subjects (n = 85). The obese and depressed patients (n = 24) showed elevated levels of IL-5, IL-12 and INF-γ compared to obese but not depressed subjects (n = 121). Levels of several cytokines were found to be associated with physical activity, employment status and presence of daily naps. The results support over-expression of pro-inflammatory cytokines in depression and extend the range of cytokines potentially associated with depression to include GM-CSF, IL-5 and IL-13. Changes in these cytokines may contribute to co-morbidity between depression and allergic and asthmatic diseases. The results also suggest inflammatory processes associated with obesity, and support an interaction between cytokine serum concentrations and behavioral aspects of both obesity and depression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Inflammation; Major depressive disorder; Obesity

Mesh:

Substances:

Year:  2014        PMID: 24838047     DOI: 10.1016/j.jpsychires.2014.04.021

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  43 in total

1.  Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury.

Authors:  Sioui Maldonado-Bouchard; Kelsey Peters; Sarah A Woller; Behrouz Madahian; Usef Faghihi; Shivani Patel; Shameena Bake; Michelle A Hook
Journal:  Brain Behav Immun       Date:  2015-08-18       Impact factor: 7.217

Review 2.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

Review 3.  [Rheumatism and the mind-A mini review].

Authors:  D Linsmayer; P-K Neidlinger; D F Braus
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

4.  The pro-inflammatory profile of depressed patients is (partly) related to obesity.

Authors:  Richard C Shelton; Michael Falola; Li Li; John Zajecka; Maurizio Fava; George I Papakostas
Journal:  J Psychiatr Res       Date:  2015-09-03       Impact factor: 4.791

Review 5.  [Nutrition and dietary supplements in psychiatric diseases].

Authors:  H Himmerich; F Erbguth
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

6.  Impact of lithium alone and in combination with antidepressants on cytokine production in vitro.

Authors:  Charlotte Petersein; Ulrich Sack; Roland Mergl; Jeremias Schönherr; Frank M Schmidt; Nicole Lichtblau; Kenneth C Kirkby; Katrin Bauer; Hubertus Himmerich
Journal:  J Neural Transm (Vienna)       Date:  2014-11-07       Impact factor: 3.575

Review 7.  Colony stimulating factors in the nervous system.

Authors:  Violeta Chitu; Fabrizio Biundo; E Richard Stanley
Journal:  Semin Immunol       Date:  2021-11-04       Impact factor: 11.130

Review 8.  Toll-Like Receptor Signaling in Depression.

Authors:  Leandra K Figueroa-Hall; Martin P Paulus; Jonathan Savitz
Journal:  Psychoneuroendocrinology       Date:  2020-09-01       Impact factor: 4.905

9.  [Predictive factors of depression and its therapy].

Authors:  H Himmerich; E Kohls; U Hegerl; C Rummel-Kluge
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

10.  Inflammatory cytokines in major depressive disorder: A case-control study.

Authors:  Paolo Cassano; Eric Bui; Andrew H Rogers; Zandra E Walton; Rachel Ross; Mary Zeng; Mireya Nadal-Vicens; David Mischoulon; Amanda W Baker; Aparna Keshaviah; John Worthington; Elizabeth A Hoge; Jonathan Alpert; Maurizio Fava; Kwok K Wong; Naomi M Simon
Journal:  Aust N Z J Psychiatry       Date:  2016-09-29       Impact factor: 5.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.